Shopping Cart
- Remove All
Your shopping cart is currently empty
BLX3887 is an inhibitor of 15-lipoxygenase type 1 (15-LO-1; IC50 = 32 nM in a cell-free enzyme assay).1 It is selective for 15-LO-1 over 15-LO-2, which it does not inhibit, 5-LO (IC50 = 472 nM), and 12-LO (IC50 = 3,310 nM). BLX3887 inhibits the production of 15-LO metabolites selectively in eosinophils over neutrophils when used at a concentration of 10 μM. It also inhibits endocytosis in, and the migration of, isolated human peripheral blood mononuclear cell-derived dendritic cells in vitro.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 500 μg | $113 | 35 days | |
| 1 mg | $218 | 35 days | |
| 5 mg | $862 | 35 days | |
| 10 mg | $1,530 | 35 days |
| Description | BLX3887 is an inhibitor of 15-lipoxygenase type 1 (15-LO-1; IC50 = 32 nM in a cell-free enzyme assay).1 It is selective for 15-LO-1 over 15-LO-2, which it does not inhibit, 5-LO (IC50 = 472 nM), and 12-LO (IC50 = 3,310 nM). BLX3887 inhibits the production of 15-LO metabolites selectively in eosinophils over neutrophils when used at a concentration of 10 μM. It also inhibits endocytosis in, and the migration of, isolated human peripheral blood mononuclear cell-derived dendritic cells in vitro. |
| Molecular Weight | 308.52 |
| Formula | C10H5Cl3FN3O |
| Cas No. | 934758-70-0 |
| Relative Density. | 1.714 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | DMF: 30 mg/mL (97.24 mM), Sonication is recommended. DMSO: 15 mg/mL (48.62 mM), Sonication is recommended. DMSO:PBS (pH 7.2) (1:5): 0.16 mg/mL (0.52 mM), Sonication is recommended. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.